Results 31 to 40 of about 53 (52)

How to effectively treat migraine attacks

open access: yesМедицинский совет, 2014
Migraine is one of the most common causes of disability of young and middle-aged people. Many patients with migraine are not satisfied with drugs used for the treatment.
V. A. Golovacheva, V. A. Parfyonov
doaj   +1 more source

VLIYaNIE ENDOVASKULYaRNYKh VMEShATEL'STV NA TEChENIE RANNEGO VOSSTANOVITEL'NOGO PERIODA U ZhENShchIN, PERENESShIKh INFARKT MIOKARDA

open access: yesКардиоСоматика, 2011
Цель исследования: изучение особенностей течения раннего восстановительного периода у женщин с инфарктом миокарда (ИМ), у которых применялись реваскуляризующие методы лечения, оценить влияние чрескожного эндова-скулярного вмешательства (ЧКВ) на течение ...
L. A. Starkova, A. A. Suvorova
doaj  

Acetylsalicylic acid in primary and secondary prevention of cardiovascular diseases. Is it all obvious?

open access: yesМедицинский совет, 2015
The review tells about the results of clinical trials and meta-analyses demonstrating the effectiveness of acetylsalicylic acid (ASA) for secondary prevention of cardiovascular diseases, namely, improved prognosis for patients after myocardial infarction
A. V. Panov, E. V. Kuleshova
doaj   +1 more source

Monitoring research of development trends range of preparations of acetylsalicylic acid on the russian pharmaceutical market

open access: yesRUDN Journal of Medicine, 2013
The tendencies in the development of the range of drugs acetylsalicylic acid in the Russian pharmaceutical market. In the process of monitoring research revealed stabilization, growth and decline in the dynamics of some indicators of structure and ...
N B Dremova
doaj  

EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES

open access: yesРациональная фармакотерапия в кардиологии, 2015
Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases is focused. Mode of ASA disaggregation action is discussed.
S. N. Tolpygina   +3 more
doaj   +1 more source

[Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)]. [PDF]

open access: yesProbl Endokrinol (Mosk), 2021
Troshina EA   +13 more
europepmc   +1 more source

Otsenka gospital'nogo etapa vedeniya molodykh patsientov, perenosyashchikh ostryy koronarnyy sindrom s pod\"emom segmenta ST

open access: yesКардиоСоматика, 2013
Цель. Оценка наличия факторов риска ишемической болезни сердца, особенностей течения заболевания, госпитального этапа ведения пациентов, перенесших острый коронарный синдром (ОКС) с подъемом сегмента ST в молодом возрастеМатериалы и методы. В исследуемую
I. S Skopets   +4 more
doaj  

АНТИТРОМБОТИЧЕСКАЯ ТЕРАПИЯ ПОСЛЕ ОСТРОГО КОРОНАРНОГО СИНДРОМА: ЧТО МЫ ЗНАЕМ О ВОЗМОЖНОСТЯХ ИНДИВИДУАЛИЗАЦИИ

open access: yesАтеротромбоз, 2016
В статье обсуждаются современные представления о подходах к антитромботической терапии после острого коронарного синдрома (ее длительность, сочетание препаратов, особенности в различных клинических ситуациях).

doaj   +1 more source

Algorithm for antithrombotic therapy in patients with ischemic stroke after thrombolysis

open access: yesМедицинский совет, 2014
Systemic thrombolytic therapy in patients with ischemic stroke is an effective treatment for a certain category of patients during the first 4.5 hours after the symptom onset.
MA Domashenko   +2 more
doaj   +1 more source

PREDICTION OF THROMBOEMBOLISM IN PATIENTS WITH LONG-LASTING ATRIAL FIBRILLATION

open access: yesЕвразийский Кардиологический Журнал, 2014
The aim of the study. Comparative analysis of the risk assessment of thromboembolism by CHADS2 and CHA2DS2-VASc scores, and to study the preventive effectiveness of different antithrombotic agents in patients with long-lasting аtrial fibrillation (AF) at
R. D. Kurbanov   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy